Regeneron, Bayer sales and marketing update

Germany’s Institute for Quality and Efficiency in Health Care (IQWiG) said in a dossier assessment that an added benefit was not proven for Eylea aflibercept ophthalmic solution ( VEGF Trap-Eye) from...